FLT3 and acute myeloid leukemia: Similarly, in AML cell lines and primary patient samples, culture with BGB324 inhibited AXL activation, induced apoptosis, and enhanced chemosensitivity to doxorubicin and cytarabine, regardless of FLT3 mutational status [9].